The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Prebiotic Effect of Fructooligosaccharides from Morinda officinalis on Alzheimer’s Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis
Open accessAbstract
Gut microbiota influences the central nervous system disorders such as Alzheimer’s disease (AD). The prebiotics and probiotics can improve the host cognition. A previous study demonstrated that fructooligosaccharides from Morinda officinalis (OMO) exert effective memory improvements in AD-like animals, thereby considered as potential prebiotics; however, the underlying mechanism still remains enigma. Thus, the present study investigated whether OMO is effective in alleviating AD by targeting the microbiota-gut-brain axis. OMO was administered in rats with AD-like symptoms (D-galactose- and Aβ 1-42-induced deficient rats). Significant and systematic deterioration in AD-like animals were identified, including learning and memory abilities, histological changes, production of cytokines, and microbial community shifts. Behavioral experiments demonstrated that OMO administration can ameliorate the learning and memory abilities in both AD-like animals significantly. AD parameters showed that OMO administration cannot only improve oxidative stress and inflammation disorder, but also regulate the synthesis and secretion of neurotransmitter. Histological changes indicated that OMO administration ameliorates the swelling of brain tissues, neuronal apoptosis, and down-regulation of the expression of AD intracellular markers (Tau and Aβ 1-42). 16S rRNA sequencing of gut microbiota indicated that OMO administration maintains the diversity and stability of the microbial community. In addition, OMO regulated the composition and metabolism of gut microbiota in inflammatory bowel disease (IBD) mice model treated by overdosed antibiotics and thus showed the prebiotic potential. Moreover, gut microbiota plays a major role in neurodevelopment, leading to alterations in gene expression in critical brain and intestinal regions, thereby resulting in perturbation to the programming of normal cognitive behaviors. Taken together, our findings suggest that the therapeutic effect of the traditional medicine, M. officinalis, on various neurological diseases such as AD, is at least partially contributed by its naturally occurring chemical constituent, OMO, via modulating the interaction between gut ecology and brain physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the administration of probiotic L plantarum MTCC1325 restored the levels of acetylcholine in the brains of D-galactose-induced AD rats by reducing AChE activity.532 Similarly, another study found that prebiotic FOS from Morinda officinalis was effective in restoring acetylcholine in the brains of d-galactose-induced AD rats by reducing AChE levels.533”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [533]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Wang, L., Feng, Z., Wang, X., Wang, X., & Zhang, X. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp612 · Cited by 4,553
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
Cabili, M. N., Trapnell, C., Goff, L. A., Koziol, M. J., Tazón‐Vega, B., Regev, A., & Rinn, J. L. (2011) · Genes & Development · doi:10.1101/gad.17446611 · Cited by 3,551
Differential analysis of gene regulation at transcript resolution with RNA-seq
Trapnell, C., Hendrickson, D. G., Sauvageau, M., Goff, L., Rinn, J. L., & Pachter, L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2450 · Cited by 3,492
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts
Sun, L. D., Luo, H., Bu, D., Zhao, G., Yu, K., Zhang, C., Liu, Y., Chen, R., & Zhao, Y. C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt646 · Cited by 2,101
Principles and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · cited 1×
“The hypothesis that the microbiota-gut-brain axis (Rhee et al., 2009) plays a critical role in health and disease, including neuropsychiatric disorders (Liu et al., 2017), is rapidly progressing.”
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
Servin, A. L. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.01.003 · Cited by 1,267
The microbiome-gut-brain axis in health and disease
Dinan, T. G., & Cryan, J. F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.007 · Cited by 1,111
Akkermansia muciniphila and its role in regulating host functions
Derrien, M., Belzer, C., & de Vos, W. M. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.005 · Cited by 1,044 · cited 2×
“is positively correlated with a lean phenotype, reduced body weight gain, amelioration of metabolic responses, and restoration of gut barrier function is effectuated by the modulation of mucus layer thickness (Bland, 2016; Derrien et al., 2016; Greer et al., 2016; Henning et al., 2017; Van Herreweghen et al., 2017).”
Flagged first, then by citations
Research works printed but not linked: 4
- Cai, 1996, Antidepressant effect of inulin- type oligosaccharides from Morinda officinalis How in mice., Chin. J. Pharmacol. Toxicol., 10, 109
- Liu, 2017, Elevated formaldehyde in the cecum of APP/PS1 mouse., Microbiol. China, 44, 1761
- Tan, Mechanism of BA-JI-SU in invigorating kidney to anti-aging., J. New Chin. Med., 32, 36
- Tan, improvement effect of bajiasu on spatial learning and memory ability of rats., Tradit. Chin. Drugs Res. Clin. Pharmacol., 11, 95
Cited by
Sorted by citations
Items 201–229 of 229
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Wang, Y., Jing, G., Fu, Y., Li, Y., & Wu, C. (2024) · Diseases & Research · doi:10.54457/dr.202401007 · Cited by 1
PREBIOTICS FOR ACUTE ISCHEMIC STROKE
Renamastika, S. N., Wahyuningrum, D. R., PUTRI, V. A., & Aisy, R. (2021) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2021v13i5.41110 · Cited by 1
Papel de la microbiota intestinal en el desarrollo de la enfermedad de Alzheimer
Martín, I. F. (2021) · Ambiociencias · doi:10.18002/ambioc.v0i18.6565
Gut Dysbiosis and Neurological Disorders—An Eclectic Perspective
Bostancıklıoğlu, M., & Demir, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00041-3 · Cited by 1
Wang, S. S. (2018) · Annals of Advanced Biomedical Sciences · doi:10.23880/aabsc-16000106
Histamine Regulates BDNF Catabolism By Specific Gut MicrobesPreprint
Luo, Q., Shi, R., Liu, Y., Huang, L., Chen, W., & Wang, C. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4047089
Xu, T., Xu, T., Han, Z.-Y., Dou, Y.-H., Shi, B., Dou, Y., Yang, J., Wang, Y., Chen, J., & Huang, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4052315
Self-citationYe, Z., Li, R., Wang, C., & Zhao, W. (2022) · Advances in Translational Medicine · doi:10.55976/atm.12022112045-60
Study on the Mechanism of Intestinal Microbiota in Alzheimer’s Disease
车, 土. (2022) · Advances in Microbiology · doi:10.12677/amb.2022.114023
Fructan Accumulators in a Changing World Climate: Chances for New Functional Plants
Witzel, K., & Matros, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85410-8.00003-x
Neurological Interactions with Microbiomes
Saar, R., & Dodd, S. A. S. (2023) · doi:10.1002/9781119862611.ch16
Research Progress in the Treatment of Alzheimer’s Disease Based on Microbiota-Gut-Brain Axis
张, 蝶. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122870
Luo, Z., Chen, Z., Liu, M., Li, Y., Zhao, Z., Yang, D., & Ding, P. (2022) · Figshare · doi:10.6084/m9.figshare.20521068
Luo, Z., Chen, Z., Liu, M., Yang, L., Zhao, Z., Yang, D., & Ding, P. (2022) · Figshare · doi:10.6084/m9.figshare.20521071
Impact of physical activity on the development of Alzheimer's disease
Paśnik, J., Sendecka, G., Kistela, N., Hądzlik, I., Durowicz, M., & Piotrowski, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.71.51112 · Cited by 1
Role of Probiotic Microorganisms in the Brain Plasticity Development
Mukilan, M., Adithya, R., & Pruthivi, S. (2024) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2024.12(3).354.365 · Cited by 1
Guo, Y., Hirad, A. H., & Alarfaj, A. A. (2025) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-024-00594-9
The impact of probiotics on cognitive function in elderly patients: a narrative review
Xiong, C., Zhai, W., Chen, X., Lan, L., & Zhang, X. (2025) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000436
Luo, Z., Chen, Z., Liu, M., Yang, L., Zhao, Z., Yang, D., & Ding, P. (2022) · Figshare · doi:10.6084/m9.figshare.20521074
Functional foods and nutraceuticals as neuroprotectors
Ferreira, C., Vieira, P. G. S., Rincón, E. O., Reis, F., & Viana, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33841-0.00014-2
Chaudhary, R., Bansal, N., Lal, R., Kaur, A., Bishnoi, M., Kondepudi, K. K., Chopra, K., & Bansal, S. (2026) · Food & Function · doi:10.1039/d5fo03823e · Cited by 1
Nicolas, S., & Nolan, Y. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00003-6
Gonçalves, L. V. P., Holanda, P. F. D. G., Cabral, A. V. D. S., Nunes, R. G. D. S., Lira, Y. V. D. S., Costa, M. R., Mendonça, I. P., de lima, A. A., de Oliveira, Ê. A. G., Peixoto, C. A., et al. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2649604 · Cited by 1
Das, K., Khatun, R., Begum, S., Bhattacharyya, K., Datta, M., Saha, D., Sarma, A., Mehta, P., & Das, B. K. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01922-9
Kumar, N., & Yarlagadda, V. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00255
Han, D., & Yang, C. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1815265
Che, Y., Zhang, Z., Zhai, Q., Zhao, J., Chen, W., Mao, X., & Wang, G. (2026) · Journal of Future Foods · doi:10.1016/j.jfutfo.2026.08.025
Chaudhary, R., Bansal, N., Kaur, A., Gupta, S., Chopra, K., & Bansal, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12492-5
Metadata
- Authors
- Chen, D., Yang, X., Yang, J., Lai, G., Yong, T., Tang, X., Shuai, O., Zhou, G., Xie, Y., & Wu, Q.
- Affiliations
- Chinese Academy of Sciences (CN)
- Guangzhou Medical University (CN)
- Guangxi University of Chinese Medicine (CN)
- Corresponding author
- Chen, Diling
- Xie, Yizhen
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-12-08
- Volume
- 9
- Pages
- 403-403
- ISSN
- 1663-4365 (ISSN-L)
- PMC
- PMC5727096
- OpenAlex
- W2775686313
- Cited by
- 227
- References
- 70
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 31 · 2023: 29 · 2022: 42 · 2021: 36 · 2020: 23 · 2019: 13 · 2018: 9
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2025-05-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Aging Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Guangzhou Medical University (2016C28)
- Guangdong Academy of Sciences (2016GDASRC-0102)
- Guangzhou Municipal Science and Technology Project
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- fructooligosaccharides, Morinda officinalis, Alzheimer's disease, prebiotics, microbiota-gut-brain axis, gut microbiota, learning and memory, oxidative stress, neuroinflammation, amyloid-beta, tau protein, neuronal apoptosis, antibiotic-induced dysbiosis, inflammatory bowel disease, traditional medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
